ADIL Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-12-30 | Stilley William B. III | director | 1,020,979 | D-Return | D | 166,667 | 0.00 | 0.00 |
| 2022-09-20 | Claiborne Cary J | director, officer: Chief Executive Officer | 1,100,000 | A-Award | A | 75,000 | 0.42 | 31,515.00 |
| 2022-09-19 | Claiborne Cary J | director, officer: Chief Executive Officer | 1,025,000 | A-Award | A | 25,000 | 0.43 | 10,735.00 |
| 2022-08-22 | Stilley William B. III | director | 100,000 | A-Award | A | 100,000 | 0.56 | 55,500.00 |
| 2022-08-18 | Claiborne Cary J | officer: Chief Executive Officer | 1,000,000 | A-Award | A | 1,000,000 | 0.00 | 0.00 |
| 2022-06-27 | Goodman Tony | director | 25,000 | A-Award | A | 25,000 | 1.23 | 30,750.00 |
| 2022-02-23 | Johnson Bankole A. | officer: Chief Medical Officer | 35,000 | A-Award | A | 35,000 | 2.00 | 70,000.00 |
| 2022-02-23 | Goodman Tony | director | 40,000 | A-Award | A | 40,000 | 2.00 | 80,000.00 |
| 2022-02-23 | Truluck Joseph | officer: Chief Financial Officer | 100,000 | A-Award | A | 100,000 | 2.00 | 200,000.00 |
| 2022-02-23 | Stilley William B. III | director, officer: Chief Executive Officer | 1,187,646 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2022-02-23 | Gilliland Robertson H. | director | 40,000 | A-Award | A | 40,000 | 2.00 | 80,000.00 |
| 2022-02-23 | Newman James W. Jr. | director | 40,000 | A-Award | A | 40,000 | 2.00 | 80,000.00 |
| 2022-02-23 | Schuyler Kevin | director | 40,000 | A-Award | A | 40,000 | 2.00 | 80,000.00 |
| 2022-02-23 | Claiborne Cary J | officer: Chief Operating Officer | 6,667 | A-Award | A | 6,667 | 2.00 | 13,334.00 |
| 2022-02-23 | Anderson J. Kermit | director | 40,000 | A-Award | A | 40,000 | 2.00 | 80,000.00 |
| 2021-12-30 | Newman James W. Jr. | director | 34,644 | P-Purchase | A | 10,000 | 2.71 | 27,100.00 |
| 2021-12-30 | Newman James W. Jr. | director | 50,221 | P-Purchase | A | 5,000 | 2.72 | 13,600.00 |
| 2021-12-30 | Newman James W. Jr. | director | 20,000 | P-Purchase | A | 10,000 | 2.66 | 26,600.00 |
| 2021-12-23 | Schuyler Kevin | director, 10 percent owner | 0 | G-Gift | D | 90,000 | 6.25 | 562,500.00 |
| 2021-12-23 | Schuyler Kevin | director, 10 percent owner | 0 | G-Gift | D | 90,000 | 6.25 | 562,500.00 |
| 2021-12-07 | Claiborne Cary J | director, officer: Chief Operating Officer | 130,000 | A-Award | A | 130,000 | 2.77 | 360,100.00 |
| 2021-11-30 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 937,646 | P-Purchase | A | 10,600 | 2.75 | 29,178.62 |
| 2021-11-29 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 927,046 | P-Purchase | A | 10,000 | 2.59 | 25,892.00 |
| 2021-11-26 | Newman James W. Jr. | director | 34,475 | P-Purchase | A | 10,000 | 2.85 | 28,500.00 |
| 2021-11-02 | Claiborne Cary J | director | 60,000 | A-Award | A | 60,000 | 3.15 | 189,000.00 |
| 2021-10-04 | Johnson Bankole A. | officer: Chief Medical Officer | 39,714 | J-Other | D | 150,000 | 0.00 | 0.00 |
| 2021-10-04 | Johnson Bankole A. | officer: Chief Medical Officer | 148,246 | S-Sale | D | 200,000 | 0.00 | 0.00 |
| 2021-04-06 | Johnson Bankole A. | officer: Chief Medical Officer | 548,336 | S-Sale | D | 150,000 | 2.50 | 375,000.00 |
| 2021-02-08 | Gilliland Robertson H. | director | 40,000 | A-Award | A | 40,000 | 3.11 | 124,400.00 |
| 2021-02-08 | Truluck Joseph | director, officer: Chief Financial Officer | 125,000 | A-Award | A | 125,000 | 0.00 | 0.00 |
| 2021-02-08 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 250,000 | A-Award | A | 250,000 | 3.11 | 777,500.00 |
| 2021-02-08 | Goodman Tony | director | 40,000 | A-Award | A | 40,000 | 3.11 | 124,400.00 |
| 2021-02-08 | Anderson J. Kermit | director | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2021-02-08 | Schuyler Kevin | director | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2021-02-08 | Newman James W. Jr. | director | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2021-01-26 | Newman James W. Jr. | director | 152,963 | A-Award | A | 2,544 | 0.00 | 0.00 |
| 2021-01-26 | Newman James W. Jr. | director | 14,475 | A-Award | A | 1,187 | 0.00 | 0.00 |
| 2021-01-26 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 917,046 | A-Award | A | 201,109 | 0.00 | 0.00 |
| 2020-11-23 | Schuyler Kevin | director | 0 | G-Gift | D | 1,010 | 0.01 | 5.45 |
| 2020-11-23 | Schuyler Kevin | director | 82,461 | G-Gift | A | 82,461 | 0.00 | 0.00 |
| 2020-11-23 | Schuyler Kevin | director | 8,649 | G-Gift | A | 8,649 | 0.00 | 0.00 |
| 2020-11-23 | Schuyler Kevin | director | 1,010 | G-Gift | A | 1,010 | 0.01 | 5.45 |
| 2020-11-23 | Schuyler Kevin | director | 89,600 | G-Gift | A | 89,600 | 0.00 | 0.00 |
| 2020-08-20 | Johnson Bankole A. | officer: Chief Medical Officer | 1,055 | S-Sale | D | 350,000 | 1.21 | 423,500.00 |
| 2020-05-19 | REICH JACK W | director | 90,000 | A-Award | A | 90,000 | 1.47 | 132,300.00 |
| 2020-03-27 | Newman James W. Jr. | director | 14,644 | P-Purchase | A | 4,644 | 1.35 | 6,269.40 |
| 2020-03-27 | Newman James W. Jr. | director | 13,288 | P-Purchase | A | 10,000 | 1.34 | 13,400.00 |
| 2020-03-27 | Newman James W. Jr. | director | 15,000 | P-Purchase | A | 5,000 | 1.42 | 7,100.00 |
| 2020-03-26 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 715,937 | P-Purchase | A | 12,652 | 1.47 | 18,598.44 |
| 2020-03-25 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 703,285 | P-Purchase | A | 12,348 | 1.13 | 13,953.24 |
| 2020-03-03 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 690,937 | A-Award | A | 54,167 | 0.00 | 0.00 |
| 2020-03-03 | Newman James W. Jr. | director | 60,000 | A-Award | A | 60,000 | 1.44 | 86,400.00 |
| 2020-03-03 | Goodman Tony | director | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
| 2020-03-03 | Schuyler Kevin | director | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
| 2020-03-03 | Truluck Joseph | director, officer: Chief Financial Officer | 107,639 | A-Award | A | 27,084 | 0.00 | 0.00 |
| 2020-03-03 | Truluck Joseph | director, officer: Chief Financial Officer | 200,000 | A-Award | A | 20,000 | 1.44 | 28,800.00 |
| 2020-03-03 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 460,000 | A-Award | A | 460,000 | 1.44 | 662,400.00 |
| 2020-03-03 | Anderson J. Kermit | director | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
| 2020-03-03 | Gilliland Robertson H. | director | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
| 2019-12-12 | Johnson Bankole A. | officer: Chief Medical Officer | 698,336 | S-Sale | D | 150,000 | 1.00 | 150,000.00 |
| 2019-10-02 | Johnson Bankole A. | officer: Chief Medical Officer | 351,055 | A-Award | A | 3,187 | 0.00 | 0.00 |
| 2019-03-29 | Johnson Bankole A. | officer: Chief Medical Officer | 347,868 | P-Purchase | A | 600 | 3.30 | 1,978.02 |
| 2019-03-29 | Johnson Bankole A. | officer: Chief Medical Officer | 344,768 | P-Purchase | A | 30,000 | 3.47 | 104,154.00 |
| 2019-03-29 | Johnson Bankole A. | officer: Chief Medical Officer | 347,268 | P-Purchase | A | 2,500 | 3.47 | 8,669.00 |
| 2019-03-28 | Johnson Bankole A. | officer: Chief Medical Officer | 314,768 | P-Purchase | A | 40,000 | 3.15 | 125,808.00 |
| 2019-03-24 | Johnson Bankole A. | officer: Chief Medical Officer | 250,000 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2019-03-10 | Truluck Joseph | director, officer: Chief Financial Officer | 180,000 | A-Award | A | 180,000 | 0.00 | 0.00 |
| 2019-03-10 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 500,000 | A-Award | A | 500,000 | 3.39 | 1,695,000.00 |
| 2018-11-12 | Schuyler Kevin | director | 89,600 | J-Other | A | 89,600 | 5.00 | 448,000.00 |
| 2018-11-12 | Schuyler Kevin | director | 192,600 | J-Other | A | 192,600 | 0.00 | 0.00 |
| 2018-11-12 | Johnson Bankole A. | officer: Chief Medical Officer | 17,600 | J-Other | A | 17,600 | 5.00 | 88,000.00 |
| 2018-11-12 | Johnson Bankole A. | officer: Chief Medical Officer | 0 | J-Other | D | 17,600 | 5.00 | 88,000.00 |
| 2018-11-12 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 0 | J-Other | D | 36,800 | 5.00 | 184,000.00 |
| 2018-11-12 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 36,800 | J-Other | A | 36,800 | 5.00 | 184,000.00 |
| 2018-11-12 | Schuyler Kevin | director | 162,200 | J-Other | A | 162,200 | 0.00 | 0.00 |
| 2018-11-12 | Schuyler Kevin | director | 120,000 | J-Other | A | 120,000 | 5.00 | 600,000.00 |
| 2018-11-12 | Schuyler Kevin | director | 0 | J-Other | D | 120,000 | 5.00 | 600,000.00 |
| 2018-11-12 | Newman James W. Jr. | director | 20,000 | J-Other | A | 20,000 | 5.00 | 100,000.00 |
| 2018-11-12 | Newman James W. Jr. | director | 92,000 | J-Other | A | 92,000 | 0.00 | 0.00 |
| 2018-11-12 | Newman James W. Jr. | director | 0 | J-Other | D | 20,000 | 5.00 | 100,000.00 |
| 2018-07-31 | Schuyler Kevin | director | 202,461 | J-Other | A | 120,000 | 0.00 | |
| 2018-07-31 | Schuyler Kevin | director | 292,461 | P-Purchase | A | 90,000 | 0.00 | |
| 2018-07-31 | Schuyler Kevin | director | 113,800 | J-Other | A | 113,800 | 0.00 | |
| 2018-07-31 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 372,402 | J-Other | A | 36,800 | 0.00 | |
| 2018-07-31 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 504,000 | P-Purchase | A | 80,000 | 0.00 | |
| 2018-07-31 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 36,800 | J-Other | A | 36,800 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 0 | C-Conversion | D | 29,931 | 0.44 | 13,169.64 |
| 2018-07-31 | Johnson Bankole A. | officer: Chief Medical Officer | 169,314 | P-Purchase | A | 1,400 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 35,094 | J-Other | A | 20,000 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 20,000 | J-Other | A | 20,000 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 102,000 | P-Purchase | A | 10,000 | 0.00 | |
| 2018-07-31 | Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 169,027 | P-Purchase | A | 80,000 | 0.00 | |
| 2018-07-31 | Johnson Bankole A. | officer: Chief Medical Officer | 17,600 | J-Other | A | 17,600 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 58,419 | C-Conversion | A | 21,715 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 5,178 | J-Other | A | 5,178 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 25,178 | J-Other | A | 20,000 | 0.00 | |
| 2018-07-31 | Newman James W. Jr. | director | 140,419 | J-Other | A | 92,000 | 0.00 | |
| 2018-07-31 | Truluck Joseph | director, officer: Chief Financial Officer | 80,555 | C-Conversion | A | 5,927 | 0.44 | 2,607.88 |
| 2018-07-31 | Truluck Joseph | director, officer: Chief Financial Officer | 0 | C-Conversion | D | 5,927 | 0.44 | 2,607.88 |
| 2018-07-31 | Truluck Joseph | director, officer: Chief Financial Officer | 5,927 | C-Conversion | A | 5,927 | 0.44 | 2,607.88 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.